Correlation Between Moleculin Biotech and Alto Neuroscience,
Can any of the company-specific risk be diversified away by investing in both Moleculin Biotech and Alto Neuroscience, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Moleculin Biotech and Alto Neuroscience, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Moleculin Biotech and Alto Neuroscience,, you can compare the effects of market volatilities on Moleculin Biotech and Alto Neuroscience, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Moleculin Biotech with a short position of Alto Neuroscience,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Moleculin Biotech and Alto Neuroscience,.
Diversification Opportunities for Moleculin Biotech and Alto Neuroscience,
-0.34 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Moleculin and Alto is -0.34. Overlapping area represents the amount of risk that can be diversified away by holding Moleculin Biotech and Alto Neuroscience, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Alto Neuroscience, and Moleculin Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Moleculin Biotech are associated (or correlated) with Alto Neuroscience,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Alto Neuroscience, has no effect on the direction of Moleculin Biotech i.e., Moleculin Biotech and Alto Neuroscience, go up and down completely randomly.
Pair Corralation between Moleculin Biotech and Alto Neuroscience,
Given the investment horizon of 90 days Moleculin Biotech is expected to generate 1.36 times more return on investment than Alto Neuroscience,. However, Moleculin Biotech is 1.36 times more volatile than Alto Neuroscience,. It trades about 0.06 of its potential returns per unit of risk. Alto Neuroscience, is currently generating about 0.04 per unit of risk. If you would invest 262.00 in Moleculin Biotech on August 27, 2024 and sell it today you would earn a total of 11.00 from holding Moleculin Biotech or generate 4.2% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Moleculin Biotech vs. Alto Neuroscience,
Performance |
| Timeline |
| Moleculin Biotech |
| Alto Neuroscience, |
Moleculin Biotech and Alto Neuroscience, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Moleculin Biotech and Alto Neuroscience,
The main advantage of trading using opposite Moleculin Biotech and Alto Neuroscience, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Moleculin Biotech position performs unexpectedly, Alto Neuroscience, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Alto Neuroscience, will offset losses from the drop in Alto Neuroscience,'s long position.| Moleculin Biotech vs. Pulmatrix | Moleculin Biotech vs. Cyclacel Pharmaceuticals | Moleculin Biotech vs. Akari Therapeutics PLC | Moleculin Biotech vs. Bio Path Holdings |
| Alto Neuroscience, vs. Capricor Therapeutics | Alto Neuroscience, vs. Soleno Therapeutics | Alto Neuroscience, vs. Bio Path Holdings | Alto Neuroscience, vs. Moleculin Biotech |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Equity Valuation Check real value of public entities based on technical and fundamental data |